Graftys SA, Pôle d'activités d'Aix en Provence, Aix en Provence, France.
SUBATECH, UMR CNRS 6457, IMT Atlantique Bretagne-Pays de la Loire, Nantes, France.
J Biomed Mater Res B Appl Biomater. 2020 Feb;108(2):367-376. doi: 10.1002/jbm.b.34395. Epub 2019 Apr 29.
The in vivo resorption rate of two injectable apatitic calcium phosphate cements used in clinics (Graftys® HBS and NORIAN®) was compared, using a good laboratory practice (GLP) study based on an animal model of critical-sized bone defect. To rationalize the markedly different biological properties observed for both cements, key physical features were investigated, including permeability and water-accessible porosity, total porosity measured by mercury intrusion and gravimetry, and microstructure. Due to a different concept for creating porosity between the two cements investigated in this study, a markedly different microstructural arrangement of apatite crystals was observed in the intergranular space, which was found to significantly influence both the mechanical strength and in vivo degradation of the two calcium phosphate cements.
本研究采用基于临界尺寸骨缺损动物模型的良好实验室规范(GLP)研究,比较了两种临床应用的可注射磷灰石钙水泥(Graftys® HBS 和 NORIAN®)的体内吸收率。为了合理化观察到的两种水泥明显不同的生物学特性,研究考察了关键物理特性,包括渗透性和可及水孔隙率、汞压入法和重量法测量的总孔隙率,以及微观结构。由于本研究中研究的两种水泥在制造孔隙方面的概念不同,因此在颗粒间空间中观察到的磷灰石晶体的微观结构排列明显不同,这显著影响了两种钙磷水泥的机械强度和体内降解。